Alphanate, Antihemophilic Factor/von Willebrand Factor Complex (Human)_美国药品上市后承诺数据库

Alphanate, Antihemophilic Factor/von Willebrand Factor Complex (Human)

申请企业

Grifols Biologicals LLC

药品名称

Alphanate, Antihemophilic Factor/von Willebrand Factor Complex (Human)

状态

延迟

承诺描述

Conduct a study to evaluate the immunogenic potential of the terminal heat-treated product.

承诺状态描述

The study completion date has passed, and the study has not yet been completed.

报告接收日期

2020/9/24 0:00:00

批准日期

1978/8/15 0:00:00

截止日期

2011/2/15 0:00:00

CDER/CBER

CB

子类型标记

最新招商产品更多>>

浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　

浙公网安备:33068302000535
　医药代理商群１：

医药代理商群２：

医药代理商群３：